Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Goodwill (2016 - 2025)

United Therapeutics' Goodwill history spans 16 years, with the latest figure at $32.3 million for Q4 2025.

  • On a quarterly basis, Goodwill changed 0.0% to $32.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $32.3 million, a 0.0% change, with the full-year FY2025 number at $32.3 million, changed 0.0% from a year prior.
  • Goodwill hit $32.3 million in Q4 2025 for United Therapeutics, roughly flat from $32.3 million in the prior quarter.
  • Over the last five years, Goodwill for UTHR hit a ceiling of $33.7 million in Q4 2023 and a floor of $4.3 million in Q3 2024.
  • Historically, Goodwill has averaged $27.2 million across 5 years, with a median of $28.0 million in 2021.
  • Biggest five-year swings in Goodwill: grew 20.36% in 2023 and later dropped 4.15% in 2024.
  • Tracing UTHR's Goodwill over 5 years: stood at $28.0 million in 2021, then changed by 0.0% to $28.0 million in 2022, then increased by 20.36% to $33.7 million in 2023, then dropped by 4.15% to $32.3 million in 2024, then changed by 0.0% to $32.3 million in 2025.
  • Business Quant data shows Goodwill for UTHR at $32.3 million in Q4 2025, $32.3 million in Q4 2024, and $4.3 million in Q3 2024.